Amgen Slovakia s.r.o.

Active
IČO 45921610limited liability company (s.r.o.)Founded 2010Bratislava - mestská časť Staré Mesto

Key figures

56 243 334 €-1,2%
Revenue 2025
+6,1%
Average annual growth 2020–2025
020 m40 m60 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 3 127 366 € (100 % of distributable profit).

History
20253 127 366 €
20243 802 195 €
20230 €
20223 245 780 €
20210 €

Summary: Amgen Slovakia s.r.o.

What kind of company is it?

Amgen Slovakia s.r.o. (IČO 45921610) is a limited liability company (s.r.o.). The company was incorporated in 2010 and has existed for 16 years. Registered office according to the register: Bratislava - mestská časť Staré Mesto. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 25–49 employees.

Who runs the company and who owns it?

The statutory body has 2 members. According to the register, the company has 2 shareholders. The registered capital is 5 000 €.

How is the company doing financially?

Revenue for 2025 was 56 243 334 €, down 1,2 % on the previous year (56 936 996 €). From 2020 to 2025, revenue grew by an average of 6,1 % per year. Net profit for 2025 was 1 397 114 € (2,5 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 4 342 478 €. At the end of 2025 the company had total assets of 30 813 990 € and equity of 1 402 614 € (equity ratio 4,6 %).

What should you look out for?

At the end of 2025 the ratio of equity to liabilities was below 8 to 100; under Section 67a of the Slovak Commercial Code the company may be considered a company in crisis.

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 19. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)51 919 46653 932 12253 932 12256 936 99656 243 334
Profit for the reporting year1 373 1531 344 0781 476 3121 651 0541 397 114
Retained earnings of previous periods4 330 7452 458 1183 802 1951 476 3120
Total assets22 980 78025 375 84523 348 58427 265 62830 813 990
Total liabilities17 232 48321 537 95318 043 08424 119 97329 404 686
Total equity5 709 3983 807 6965 284 0073 132 8661 402 614
Calculated dividends03 245 78003 802 1953 127 366

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
85 %15 %directordirectorproxy holderproxy holderAmgen Slovakia s.r.o.Amgen Slovakia s.r.o.AMGEN WORLDWIDEHOLDINGS B.V.AMGEN WORLDWIDE HOLDINGS B.V.AMGENINTERNATIONAL LLCAMGEN INTERNATIONAL LLCESIng. Eva SolovičováIng. Eva SolovičováDBMUDr. Dagmar BuckováMUDr. Dagmar BuckováMBMgr. Martin BorskýMgr. Martin BorskýZDMVDr. ZuzanaDemeterováMVDr. Zuzana Demeterová
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements17

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4646)
Amgen Slovakia s.r.o. (IČO 45921610) – revenue 56,2M € | icoprofil.sk